Skip to main content

Table 3 Estimates of the effect of covariates on 28- and 90-day mortality as evaluated in the eight Cox proportional hazards models

From: Association between incident delirium and 28- and 90-day mortality in critically ill adults: a secondary analysis

Variable

Mortality at 28 days

Mortality at 90 days

Model

Incident delirium

Days of delirium

Days of coma

Days of delirium or coma

Incident delirium

Days of delirium

Days of coma

Days of delirium or coma

Age

1.04 (1.03–1.06)

1.04 (1.03–1.06)

1.05 (1.03–1.06)

1.04 (1.03–1.05)

1.04 (1.03–1.05)

1.04 (1.03–1.05)

1.04 (1.03–1.05)

1.04 (1.03–1.05)

APACHE II score

1.07 (1.06–1.09)

1.07 (1.06–1.09)

1.07 (1.05–1.09)

1.07 (1.06–1.09)

1.07 (1.05–1.08)

1.07 (1.05–1.08)

1.06 (1.05–1.08)

1.06 (1.05–1.08)

Sepsis present

1.89 (1.46–2.43)

1.87 (1.45–2.42)

1.73 (1.33–2.24)

1.87 (1.45–2.42)

1.86 (1.48–2.33)

1.85 (1.47–2.33)

1.72 (1.36–2.17)

1.78 (1.41–2.25)

Mechanical ventilation use

2.81 (1.88–4.19)

2.77 (1.86–4.13)

2.24 (1.50–3.36)

2.49 (1.66–3.72)

2.16 (1.54–3.05)

2.14 (1.53–3.00)

1.83 (1.30–2.58)

1.95 (1.38–2.74)

ICU Length of Stay

0.97 (0.95–0.99)

0.97 (0.96–0.99)

0.92 (0.90–0.95)

0.95 (0.92–0.97)

1.00 (0.98–1.01)

1.00 (0.98–1.01)

0.97 (0.95–0.99)

0.98 (0.97–1.00)

Study Arm

 Haloperidol 2 mg

1.08 (0.78–1.49)

1.06 (0.76–1.47)

1.20 (0.87–1.66)

1.29 (0.93–1.78)

1.17 (0.88–1.56)

1.18 (0.89–1.58)

1.31 (0.98–1.74)

0.97 (0.76–1.25)

 Haloperidol 1 mg

1.18 (0.84–1.66)

1.16 (0.83–1.64)

1.12 (0.79–1.58)

1.21 (0.86–1.71)

1.15 (0.84–1.57)

1.15 (0.84–1.57)

1.16 (0.85–1.60)

0.99 (0.73–1.35)

  1. Data is present as hazard ratios with their associated 95% confidence intervals